logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
T

Thomas Powles

barts health nhs trust

33H指数
221论文数
1.3W被引数
收录论文 53
发表时间
logo
Combination with BCG induction and maintenance therapy for high-risk non-muscle invasive bladder cancer.BCG诱导和维持治疗联合用于高危非肌层浸润性膀胱癌。
errAnnals of Oncology
IF65.4
err2025-10-17
err0
PREAI
errJ.J. Meeks; T. Powles
err分享
err收藏
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial度伐利尤单抗联合BCG用于BCG-naive高危非肌层浸润性膀胱癌（POTOMAC）：一项随机、开放标签、III期试验的最终分析
errThe Lancet
IF97.3
err2025-10-17
err0
PREAI
errMaria De Santis; Joan Palou Redorta; Hiroyuki Nishiyama; Michał Krawczyński; Artur Seyitkuliev; Andrey Novikov; Félix Guerrero-Ramos; Ruslan Zukov; Minoru Kato; Takashi Kawahara; Lieven Goeman; Javier Puente; Eva Hellmis; Thomas Powles; Piotr Radziszewski; Kilian M Gust; Paul Vasey; Pierre Bigot; Yves Fradet; Jarmo Hunting; Jon Armstrong; Suliman Boulos; Stephan Hois; Neal D Shore
err分享
err收藏
Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of belzutifan versus everolimus in previously treated advanced renal cell carcinoma (RCC): LITESPARK-005 (LS-005)belzutifan与everolimus在既往治疗过的晚期肾细胞癌（RCC）中的质量调整无症状或无毒性时间（Q-TWiST）分析：LITESPARK-005（LS-005）
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errPowles, Thomas; De Velasco, Guillermo; Choueri, Toni; Chen, Gregory; Xiao, Ying; Shinde, Reshme; Moneuse, Patrick; Del Fava, Emanuele; Perini, Rodolfo; Vickery, Donna; Albiges, Laurence; Rini, Brian
err分享
err收藏
Final results of the phase 3 COSMIC-313 study comparing first-line cabozantinib plus nivolumab and ipilimumab with nivolumab plus ipilimumab in patients with advanced renal-cell carcinomaIII期COSMIC-313研究的最终结果：比较卡博赞替尼联合纳武利尤单抗和伊匹木单抗与纳武利尤单抗联合伊匹木单抗在晚期肾细胞癌患者中的一线治疗。
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errAlbiges, Laurence; Motzer, Robert; Aguirre, Sergio Arnoldo Trevino; Kanesvaran, Ravindran; Centkowski, Piotr; Reimers, Melissa A.; Sade, Juan Pablo; Pouessel, Damien; Biscaldi, Elisa; Esteban, Emilio; Angel, Jose; Arija, Arranz; Tykodi, Scott; Ma, Haijun; Zhou, Lei; Losio, Maximiliano van Kooten; Simmons, Andrew; Braun, David; Choueri, Toni; Powles, Thomas
err分享
err收藏
CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor–based Combination Therapy in Patients with Metastatic Renal Cell CarcinomaCaboPoint：一项关于在转移性肾细胞癌患者中，在基于检查点抑制剂联合疗法之后进行二线卡博替尼治疗的研究
errEuropean Urology
IF25.2
err2025-09-30
err0
PREAI
errLaurence Albiges; Thomas Powles; Anand Sharma; Balaji Venugopal; Jens Bedke; Angelika Borkowetz; Gwenaelle Gravis; Berna C. Özdemir; Marco Julius Schnabel; Pascale Dutailly; Bryan Qvick; Valerie Perrot; Viktor Grünwald
err分享
err收藏
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial来自随机III期CheckMate 9ER试验的尼鲁单抗联合卡博赞替尼治疗晚期肾细胞癌的最终分析
errAnnals of Oncology
IF65.4
err2025-09-23
err0
errOAAI
errR.J. Motzer; B. Escudier; M. Burotto; T. Powles; A.B. Apolo; M.T. Bourlon; A.Y. Shah; C. Porta; C. Suárez; C.H. Barrios; M. Richardet; H. Gurney; E.R. Kessler; Y. Tomita; J. Bedke; C. Scheffold; M. Askelson; J. Panzica; J. Zhang; M. van Kooten Losio; T.K. Choueiri
err分享
err收藏
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trialTAR-200联合西特雷利单抗与西特雷利单抗单药治疗作为不适合或拒绝新辅助顺铂为基础化疗的肌层浸润性膀胱癌患者的新辅助治疗（SunRISe-4）：一项随机、开放标签Ⅱ期试验的期中分析
errlancet oncology
IF0
err2025-08-27
err0
PREAI
errAndrea Necchi; Félix Guerrero-Ramos; Paul L Crispen; Bernardo Herrera-Imbroda; Rohan Garje; Thomas Powles; Charles C Peyton; Benjamin Pradere; Ja Hyeon Ku; Neal Shore; Martin Bögemann; Mark A Preston; Evanguelos Xylinas; Cristina Sanchez de Llano; Mohamad Hasan; Hind Stitou; Sumeet Bhanvadia; Hussein Sweiti; Sarah P Psutka
err分享
err收藏
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers肿瘤转录组范围表达分类器预测晚期前列腺癌的治疗敏感性
errCell
IF42.5
err2025-08-26
err0
errOAAI
errEmily Grist; Peter Dutey-Magni; Marina A. Parry; Larissa Mendes; Ashwin Sachdeva; James A. Proudfoot; Anis A. Hamid; Mazlina Ismail; Sarah Howlett; Stefanie Friedrich; Lia DePaula Oliveira; Laura Murphy; Christopher Brawley; Oluwademilade Dairo; Sharanpreet Lall; Yang Liu; Daniel Wetterskog; Anna Wingate; Karolina Nowakowska; Leila Zakka; Claire L. Amos; Nafisah B. Atako; Victoria Wang; Hannah L. Rush; Robert J. Jones; Hing Leung; William R. Cross; Silke Gillessen; Chris C. Parker; Teresa Marafioti; Alfonso Urbanucci; Matthew Fittall; Edward M. Schaeffer; Daniel E. Spratt; David Waugh; Thomas Powles; Matthew R. Sydes; Felix Y. Feng; Daniel M. Berney; Mahesh K.B. Parmar; Noel W. Clarke; Elai Davicioni; Tamara L. Lotan; Christopher J. Sweeney; Louise C. Brown; Nicholas D. James; Gerhardt Attard
err分享
err收藏
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study恩诺单抗维多汀联合帕博利珠单抗对比化疗在先前未经治疗的局部晚期或转移性尿路上皮癌患者中的疗效（EV-302）：一项开放标签、随机对照、III期研究的患者报告结局
errlancet oncology
IF0
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
err分享
err收藏
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinomaSTELLAR-304: zanzalintinib (XL092) 联合nivolumab治疗晚期非透明细胞肾细胞癌的III期研究
errFUTURE ONCOLOGY
IF2.6
err2025-02-26
err0
errOAAI
errPal, Sumanta K.; Powles, Thomas; Kanesvaran, Ravindran; Molina-Cerrillo, Javier; Feldman, Darren R.; Barata, Pedro; Liu, Mohan; Bhatt, Aarohi; Wang, Zhong; Nandoskar, Prachi; Suarez, Cristina
err分享
err收藏
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis接受一线治疗后转移性肾细胞癌的无治疗生存期：一项国际转移性肾细胞癌数据库联盟分析
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2025-02-01
err1
PREAI
errGupta, Mehul; Wells, Connor; Regan, Meredith M.; Xie, Wanling; Navani, Vishal; Saliby, Renee Maria; Basa, Naveen S.; Donskov, Frede; Yuasa, Takeshi; Takemura, Kosuke; Kollmannsberger, Christian K.; Crumbaker, Megan; Lalani, Aly-Khan A.; Powles, Thomas; Ebrahimi, Hedyeh; Mckay, Rana R.; Lee, Jae-Lyun; Kanesvaran, Ravindran; Choueiri, Toni K.; Heng, Daniel Y. C.
err分享
err收藏
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions肾细胞癌的新辅助和辅助免疫疗法：优势、劣势及未来方向
errEuropean Urology Oncology
IF9.3
err2024-09-01
err0
errOAAI
errLaura Marandino; Riccardo Campi; Daniele Amparore; Zayd Tippu; Laurence Albiges; Umberto Capitanio; Rachel H. Giles; Silke Gillessen; Alexander Kutikov; James Larkin; Robert J. Motzer; Phillip M. Pierorazio; Thomas Powles; Morgan Roupret; Grant D. Stewart; Samra Turajlic; Axel Bex
err分享
err收藏
ESMO Clinical Practice Guideline interim update on fi rst-line therapy in advanced urothelial carcinoma
errANNALS OF ONCOLOGY
IF65.4
err2024-06-01
err26
PREAI
errPowles, T.; Bellmunt, J.; Comperat, E.; De Santis, M.; Huddart, R.; Loriot, Y.; Necchi, A.; Valderrama, B. P.; Ravaud, A.; Shariat, S. F.; Szabados, B.; van der Heijden, M. S.; Gillessen, S.
err分享
err收藏
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trialNivolumab联合卡博替尼与舒尼替尼一线治疗晚期肾细胞癌: III期随机CheckMate 9ER试验的延长随访
errESMO OPEN
IF8.3
err2024-05-01
err18
errOAAI
errPowles, T.; Burotto, M.; Escudier, B.; Apolo, A. B.; Bourlon, M. T.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C. H.; Richardet, M.; Gurney, H.; Kessler, E. R.; Tomita, Y.; Bedke, J.; George, S.; Scheffold, C.; Wang, P.; Fedorov, V.; Motzer, R. J.; Choueiri, T. K.
err分享
err收藏
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma辅助Pembrolizumab治疗肾细胞癌的总生存率
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-04-18
err40
PREAI
errChoueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Ferguson, T.; Symeonides, S. N.; Hajek, J.; Chang, Y-H; Lee, J-L; Sarwar, N.; Haas, N. B.; Gurney, H.; Sawrycki, P.; Mahave, M.; Gross-Goupil, M.; Zhang, T.; Burke, J. M.; Doshi, G.; Melichar, B.; Kopyltsov, E.; Alva, A.; Oudard, S.; Topart, D.; Hammers, H.; Kitamura, H.; McDermott, D. F.; Silva, A.; Winquist, E.; Cornell, J.; Elfiky, A.; Burgents, J. E.; Perini, R. F.; Powles, T.
err分享
err收藏
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations
errJNCI CANCER SPECTRUM
IF4.1
err2024-04-16
err1
errOAAI
errNecchi, Andrea; Ramlau, Rodryg; Falcon Gonzalez, Alejandro; Chaudhry, Arvind; Todenhoefer, Tilman; Tahbaz, Rana; Fontana, Elisa; Giannatempo, Patrizia; Deville, Jean-Laurent; Pouessel, Damien; Yoon, Shinkyo; Powles, Thomas; Bernat, Mathieu; Hackl, Manuel; Marszewska, Michalina; McKernan, Phil; Saulay, Mikael; Scaleia, Federica; Engelhardt, Marc; Loriot, Yohann; Siefker-Radtke, Arlene; De Santis, Maria
err分享
err收藏
On the Road Towards Curing Advanced Bladder Cancer
errEUROPEAN UROLOGY FOCUS
IF5.6
err2024-03-01
err0
PREAI
errSzabados, Bernadett; Powles, Thomas
err分享
err收藏
Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy-Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling
errclinical epidemiology
IF3.2
err2023-06-01
err2
errOAAI
errGalsky, Matthew; Wirtz, Heidi S.; Bloudek, Brian; Hepp, Zsolt; Farrar, Mallory; Timmons, Jack; Lenero, Enrique; Powles, Thomas
err分享
err收藏
Evaluation of circulating tumor DNA kinetics as a prognostic biomarker for overall survival in metastatic castrate resistant prostate cancer using a novel methylation sequencing research assay
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errSweeney, Christopher; Xu, Chang; He, Jie; Young, Amanda; Robertson, Alexander; Petry, Russell; Zollinger, Daniel; Fine, Alexander; Peterman, Neil; Polisecki, Eliana; Warner, Tyler; Yuen, Kobe; Huang, Yanmei; Assaf, Zoe; Graf, Ryon; Mariathasan, Sanjeev; Hegde, Priti; Fabrizio, David; Powles, Thomas
err分享
err收藏
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium转移性肾细胞癌中同步放疗和卡博替尼的真实世界实践模式和安全性: 来自国际转移性肾细胞癌数据库联盟的结果
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2023-04-01
err6
PREAI
errGan, Chun Loo; Huang, Jiaming; Pan, Elizabeth; Xie, Wanling; Schmidt, Andrew L.; Labaki, Chris; Meza, Luis; Bouchard, Gabrielle; Li, Haoran; Jackson-Spence, Francesca; Sanchez-Ruiz, Carla; Powles, Thomas; Kumar, Shruti A.; Weise, Nicole; Hall, William A.; Rose, Brent S.; Beuselinck, Benoit; Suarez, Cristina; Pal, Sumanta K.; Choueiri, Toni K.; Heng, Daniel Y. C.; McKay, Rana R.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.5K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
S
Shahrokh F. Shariat
H 指数: 146 · 论文数: 2.9K
C
Charles G. Drake
H 指数: 133 · 论文数: 1.2K
S
Sabina Signoretti
H 指数: 130 · 论文数: 1.2K
查看更多